Article
Novel G6PC3 Mutations in Patients with Congenital Neutropenia: Case Reports and Review of the Literature.
Endocrine, metabolic & immune disorders drug targets - 1 Jan 2021
Maroufi Seyed F, Shaka Zoha, Mojtabavi Helia, Sadeghalvad Mona, Rayzan Elham, Sedighi Iraj, Shahkarami Sepideh, Najafi Mehri, Rohlfs Meino, Klein Christoph, Rezaei Nima
Abstract excerpt
BACKGROUND: Severe congenital neutropenia (SCN4) caused by mutations in glucose-6- phosphatase catalytic subunit 3 (G6PC3) is characterized by recurrent infections due to severe neutropenia, may be accompanied by other extra-hematopoietic manifestations; including structural heart defects, urogenital abnormalities, prominent superficial venous markings, growth retention, and inflammatory bowel diseases with rare...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
